| [1] |
Zheng Y, Zhou H, Fong Yee C, et al. Bone resorption increase tumor growth in a mouse model of osteosclerotic breast cancer metastasis[J]. Clin Exp Metastasis,2008,25(5):559-567.
|
| [2] |
Nicolin V, Bortul R, Bareggi R,et al. Breast adenocarcinoma MCF-7 cell line induce spontaneous osteoclastogenesis via a RANK-ligand-dependent pathway[J]. Acta Histochem,2008,110(5):388-396.
|
| [3] |
朱国英,张燕燕,顾淑珠,等.乳腺癌细胞对成骨细胞增殖和分化功能的抑制作用[J].癌症,2009,28(5):449-455.
|
| [4] |
Manolagas SC. Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis1[J].Endocrine Reviews, 2000,21 (2): 115-137.
|
| [5] |
Berrodin TJ, Chang KC, Komm BS, et al. Differential biochemical and cellular actions of premarin estrogens: distinct pharmacology of bazedoxifene-conjugated estrogens combination[J]. Mol Endocrinol,2009,23 (1): 74-85.
|
| [6] |
Yin JJ,Pollock CB,Kelly K. Mechanisms of cancer metastasis to the bone[J] . Cell Res, 2005,15(1):57-62.
|
| [7] |
Nakamura T,Imai Y,Matsumoto T, et al. Estrogen prevents bone loss via estrogen receptor alpha and induction of Fas ligand in osteoclasts[J]. Cell, 2007,130(5):811-823.
|
| [8] |
Krum SA,Miranda Carboni GA,Hauschka PV, et al. Estrogen protects bone by inducing Fas ligand in osteoblasts to regulate osteoclast survival[J]. EMBO J,2008,27(3):535-545.
|
| [9] |
Cheleuitte D, Mizuno S, Glowacki J. In vitro secretion of cytokines by human bone marrow: effects of age and estrogen status[J]. Clin Endocrinol Metab,1998, 83(6):2043-2051.
|
| [10] |
Hong DS, Angelo LS, Kurzrock R. Interleukin-6 and its receptors in cancer : Implication for translational therapeutics[J]. Cancer,2007,110(9):1911-1928.
|
| [11] |
Trinkaus M, Simmons C, Myers J, et al. Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the non-trial setting[J].Support Care Cancer,2010;8(2):197-203.
|
| [12] |
Paget S. The distribution of secondary growths in cancer of the breast.1889[J]. Cancer Metastasis Rev,1989,8(2):98-101.
|
| [13] |
杨静. 乳腺癌骨转移的分子机制[J].实用医学杂志,2003,19(12):1389-1391.
|
| [14] |
Zhang Y, Ma B, Fan Q. Mechanisms of breast cancer bone metastasis[J].Cancer Letters,2010,292(1):1-7.
|
| [15] |
Hirbe AC, Morgan EA, Weilbaecher KN. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases[J]? Curr Pharm Des, 2010,16(11):1284-1290.
|
| [16] |
Brown SA, Guise TA. Cancer treatment-related bone disease[J]. Crit Rev Eukaryot Gene Expr, 2009,19(1): 47-60.
|
| [17] |
Garland CF, Garland FC, Gorham ED, et al. The role of Vitamin D in cancer prevention[J]. Am J Public Health, 2006,96(2):252-261.
|
| [18] |
Grant WB, Mohr SB. Ecological studies of ultraviolet B, vitamin D and cancer since 2000[J]. Ann Epidemiol, 2009,19(7):446-454.
|
| [19] |
Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences[J]. Am J Clin Nutr, 2008,87(4):1080S-1086S.
|
| [20] |
Grant WB. Lower vitamin-D production from solar ultraviolet-B irradiance may explain some differences in cancer survival rates[J]. Natl Med Assoc,2006,98(3):357-364.
|
| [21] |
Zheng Y, Zhou H, Modzelewski JR, et al. Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone. Cancer Res, 2007, 67 (19):9542-9548.
|
| [22] |
Ooi LL, Zhou H, Kalak R, et al. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis[J]. Cancer Res, 2010,70(5):1835-1844.
|
| [23] |
Ooi LL, Zheng Y, Zhou H, et al. Vitamin D deficiency promotes growth of MCF-7 human breast cancer in a rodent model of osteosclerotic bone metastasis[J]. Bone,2010,47(4):795-803.
|
| [24] |
Guise TA, Mohammad KS, Clines G, et al. Basic mechanisms responsible for osteolytic and osteoblastic bone metastases[J]. Clinical Cancer Res, 2006,12(20 Pt 2):6213s-6216s.
|
| [25] |
Jesudason D, Need AG, Horowitz M, et al. Relationship between serum 25-hydroxyvitamin D and bone resorption markers in vitamin D insufficiency[J]. Bone, 2002,31(5):626-630.
|
| [26] |
任林,齐晓伟摘译. 沙戈匹隆通过抑制肿瘤细胞生长和骨质吸收从而抑制乳腺癌骨转移和骨质破坏[J/CD].中华乳腺病杂志:电子版,2009,3(5):574-576.
|
| [27] |
Chiang AC, Massague J. Molecular basis of metastasis [J]. N Eng J Med, 2008,359(26):2814-2823.
|
| [28] |
Huber DM, Bendixen AC, Pathrose P, et a1. Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factor[J].Endocrinology,2001,142(9):3800-3808
|
| [29] |
Krawetz R, Wu YE, Rancourt DE, et al. Osteoblasts suppress high bone turnover caused by osteolytic breast cancer invitro[J].Exp Cell Res,2009,315(14):2333-2342.
|
| [30] |
Yin JJ, Selander K, Chirgwin JM, et al. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development[J]. J Clin Invest 1999, 103(2):197-206.
|
| [31] |
Grady D, Cauley JA, Geiger MJ, et al. Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk[J]. Natl Cancer Inst,2008,100(12):854-861.
|
| [32] |
徐海滨,胡祖健,胡望华,等. 乳腺癌骨转移综合治疗初探[J/CD].中华乳腺病杂志:电子版,2007,1(1):4,18.
|